Molecular profiling of LGL leukemia reveals role of sphingolipid signaling in survival of cytotoxic lymphocytes

Mithun Vinod Shah, Ranran Zhang, Rosalyn Irby, Ravi Kothapalli, Xin Liu, Ty Arrington, Bryan Frank, Norman H. Lee, Thomas P. Loughran

Research output: Contribution to journalArticle

86 Citations (Scopus)

Abstract

T-cell large granular lymphocyte (LGL) leukemia is characterized by clonal expansion of CD3 +CD8 + cells. Leukemic LGLs correspond to terminally differentiated effector-memory cytotoxic T lymphocytes (CTLs) that escape Fasmediated activation-induced cell death (AICD) in vivo. The gene expression signature of peripheral blood mononuclear cells from 30 LGL leukemia patients showed profound dysregulation of expression of apoptotic genes and suggested uncoupling of activation and apoptotic pathways as a mechanism for failure of AICD in leukemic LGLs. Pathway-based microarray analysis indicated that balance of proapoptotic and antiapoptotic sphingolipid-mediated signaling was deregulated in leukemic LGLs. We further investigated sphingolipid pathways and found that acid ceramidase was constitutively overexpressed in leukemic LGLs and that its inhibition induced apoptosis of leukemic LGLs. We also showed that S1P 5 is the predominant S1P receptor in leukemic LGLs, whereas S1P 1 is down-regulated. FTY720, a functional antagonist of S1P-mediated signaling, induced apoptosis in leukemic LGLs and also sensitized leukemic LGLs to Fasmediated death. Collectively, these results show a role for sphingolipidmediated signaling as a mechanism for long-term survival of CTLs. Therapeutic targeting of this pathway, such as use of FTY720, may have efficacy in LGL leukemia.

Original languageEnglish (US)
Pages (from-to)770-781
Number of pages12
JournalBlood
Volume112
Issue number3
DOIs
StatePublished - Aug 1 2008

Fingerprint

Large Granular Lymphocytic Leukemia
Sphingolipids
T-cells
Lymphocytes
Chemical activation
Cytotoxic T-Lymphocytes
Cell death
Acid Ceramidase
Cell Death
Lysosphingolipid Receptors
Apoptosis
Microarray Analysis
Microarrays
Transcriptome
Gene expression
Blood Cells
Blood
Genes
Gene Expression
Data storage equipment

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Cite this

Shah, Mithun Vinod ; Zhang, Ranran ; Irby, Rosalyn ; Kothapalli, Ravi ; Liu, Xin ; Arrington, Ty ; Frank, Bryan ; Lee, Norman H. ; Loughran, Thomas P. / Molecular profiling of LGL leukemia reveals role of sphingolipid signaling in survival of cytotoxic lymphocytes. In: Blood. 2008 ; Vol. 112, No. 3. pp. 770-781.
@article{fa6b60f7c77b44d7bf2ba8ca98a63b18,
title = "Molecular profiling of LGL leukemia reveals role of sphingolipid signaling in survival of cytotoxic lymphocytes",
abstract = "T-cell large granular lymphocyte (LGL) leukemia is characterized by clonal expansion of CD3 +CD8 + cells. Leukemic LGLs correspond to terminally differentiated effector-memory cytotoxic T lymphocytes (CTLs) that escape Fasmediated activation-induced cell death (AICD) in vivo. The gene expression signature of peripheral blood mononuclear cells from 30 LGL leukemia patients showed profound dysregulation of expression of apoptotic genes and suggested uncoupling of activation and apoptotic pathways as a mechanism for failure of AICD in leukemic LGLs. Pathway-based microarray analysis indicated that balance of proapoptotic and antiapoptotic sphingolipid-mediated signaling was deregulated in leukemic LGLs. We further investigated sphingolipid pathways and found that acid ceramidase was constitutively overexpressed in leukemic LGLs and that its inhibition induced apoptosis of leukemic LGLs. We also showed that S1P 5 is the predominant S1P receptor in leukemic LGLs, whereas S1P 1 is down-regulated. FTY720, a functional antagonist of S1P-mediated signaling, induced apoptosis in leukemic LGLs and also sensitized leukemic LGLs to Fasmediated death. Collectively, these results show a role for sphingolipidmediated signaling as a mechanism for long-term survival of CTLs. Therapeutic targeting of this pathway, such as use of FTY720, may have efficacy in LGL leukemia.",
author = "Shah, {Mithun Vinod} and Ranran Zhang and Rosalyn Irby and Ravi Kothapalli and Xin Liu and Ty Arrington and Bryan Frank and Lee, {Norman H.} and Loughran, {Thomas P.}",
year = "2008",
month = "8",
day = "1",
doi = "10.1182/blood-2007-11-121871",
language = "English (US)",
volume = "112",
pages = "770--781",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "3",

}

Shah, MV, Zhang, R, Irby, R, Kothapalli, R, Liu, X, Arrington, T, Frank, B, Lee, NH & Loughran, TP 2008, 'Molecular profiling of LGL leukemia reveals role of sphingolipid signaling in survival of cytotoxic lymphocytes', Blood, vol. 112, no. 3, pp. 770-781. https://doi.org/10.1182/blood-2007-11-121871

Molecular profiling of LGL leukemia reveals role of sphingolipid signaling in survival of cytotoxic lymphocytes. / Shah, Mithun Vinod; Zhang, Ranran; Irby, Rosalyn; Kothapalli, Ravi; Liu, Xin; Arrington, Ty; Frank, Bryan; Lee, Norman H.; Loughran, Thomas P.

In: Blood, Vol. 112, No. 3, 01.08.2008, p. 770-781.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Molecular profiling of LGL leukemia reveals role of sphingolipid signaling in survival of cytotoxic lymphocytes

AU - Shah, Mithun Vinod

AU - Zhang, Ranran

AU - Irby, Rosalyn

AU - Kothapalli, Ravi

AU - Liu, Xin

AU - Arrington, Ty

AU - Frank, Bryan

AU - Lee, Norman H.

AU - Loughran, Thomas P.

PY - 2008/8/1

Y1 - 2008/8/1

N2 - T-cell large granular lymphocyte (LGL) leukemia is characterized by clonal expansion of CD3 +CD8 + cells. Leukemic LGLs correspond to terminally differentiated effector-memory cytotoxic T lymphocytes (CTLs) that escape Fasmediated activation-induced cell death (AICD) in vivo. The gene expression signature of peripheral blood mononuclear cells from 30 LGL leukemia patients showed profound dysregulation of expression of apoptotic genes and suggested uncoupling of activation and apoptotic pathways as a mechanism for failure of AICD in leukemic LGLs. Pathway-based microarray analysis indicated that balance of proapoptotic and antiapoptotic sphingolipid-mediated signaling was deregulated in leukemic LGLs. We further investigated sphingolipid pathways and found that acid ceramidase was constitutively overexpressed in leukemic LGLs and that its inhibition induced apoptosis of leukemic LGLs. We also showed that S1P 5 is the predominant S1P receptor in leukemic LGLs, whereas S1P 1 is down-regulated. FTY720, a functional antagonist of S1P-mediated signaling, induced apoptosis in leukemic LGLs and also sensitized leukemic LGLs to Fasmediated death. Collectively, these results show a role for sphingolipidmediated signaling as a mechanism for long-term survival of CTLs. Therapeutic targeting of this pathway, such as use of FTY720, may have efficacy in LGL leukemia.

AB - T-cell large granular lymphocyte (LGL) leukemia is characterized by clonal expansion of CD3 +CD8 + cells. Leukemic LGLs correspond to terminally differentiated effector-memory cytotoxic T lymphocytes (CTLs) that escape Fasmediated activation-induced cell death (AICD) in vivo. The gene expression signature of peripheral blood mononuclear cells from 30 LGL leukemia patients showed profound dysregulation of expression of apoptotic genes and suggested uncoupling of activation and apoptotic pathways as a mechanism for failure of AICD in leukemic LGLs. Pathway-based microarray analysis indicated that balance of proapoptotic and antiapoptotic sphingolipid-mediated signaling was deregulated in leukemic LGLs. We further investigated sphingolipid pathways and found that acid ceramidase was constitutively overexpressed in leukemic LGLs and that its inhibition induced apoptosis of leukemic LGLs. We also showed that S1P 5 is the predominant S1P receptor in leukemic LGLs, whereas S1P 1 is down-regulated. FTY720, a functional antagonist of S1P-mediated signaling, induced apoptosis in leukemic LGLs and also sensitized leukemic LGLs to Fasmediated death. Collectively, these results show a role for sphingolipidmediated signaling as a mechanism for long-term survival of CTLs. Therapeutic targeting of this pathway, such as use of FTY720, may have efficacy in LGL leukemia.

UR - http://www.scopus.com/inward/record.url?scp=50949132631&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=50949132631&partnerID=8YFLogxK

U2 - 10.1182/blood-2007-11-121871

DO - 10.1182/blood-2007-11-121871

M3 - Article

C2 - 18477771

AN - SCOPUS:50949132631

VL - 112

SP - 770

EP - 781

JO - Blood

JF - Blood

SN - 0006-4971

IS - 3

ER -